Market Research Logo

India Coronary Stent and Angioplasty Market Through 2020

India Coronary Stent and Angioplasty Market Through 2020

The coronary stent market in India, which comprises Drug Eluting Stent (DES), Bare Metal Stent (BMS) and Bio-Absorbable Stent (BVS), was valued above $330 million. DES accounts for bulk of sales in India. The bio-absorbable stent ABSORB has garnered a considerable traction despite its high cost compared with the other available DES. The key players operating in the segment are Alvimedica, Abbott Vascular, a division of Abbott Laboratories (NYSE : ABT), Boston Scientific (NYSE : BSX, LSE : BSX), Biosensors Inc., Biotronik, JW Medical, Medtronic, Inc. (NYSE : MDT), Meril Life Sciences, MicroPort Scientific Corporation (HKG:0853), Sahajanand Medical Technologies, Translumina Therapeutics and Vascular Concepts.

The market has grown impressively supported by a rise in coronary angioplasties which has resulted from a surge in cardiovascular diseases (CVDs), augmented healthcare spending as well as an increase in number of interventional cardiologists and cath labs in government and private hospitals, including individual cath lab centres run by interventional cardiologists as well as new corporate hospitals.

The demand has surged as central and state governments capped reimbursement rates which enhanced affordability resulting in an increase in volume. The decrease in reimbursement rates has given an edge to Indian, Asian and some of the Europe-based mid-sized MNCs which sell stents at almost half the price of those sold by US companies.

"In the US, the stents market has slumped significantly due to negative results from clinical studies suggesting that one-third of stent implants are unnecessary. However, in India these studies have not made an impact as most Indian cardiologists do not seem to have taken these clinical outcomes seriously," said Manoj Jiandani, CEO, ABMRG.

'India Coronary Stent and Angioplasty Market Through 2020 (Cath Lab Level Information-City, State and National)', is a market report published recently by ABMRG. It reviews historical trends and forecasts (between 2007 and 2020), annualised sales, market size (value and units), market growth, pricing, competitive landscape and market share.

The research report covers 700 cath labs across the country. It analyses angioplasty procedures' (PCI and PTCA) data for the country with a detailed analysis at national, state, district, city and hospital levels. It provides PCI data of 550 hospitals from more than 150 cities. ""No one has covered cath labs in India like us,"" Jiandani said.

The report offers a proprietary cross-category comparison for products and geographies for the historical and forecast period. It also lists strategic developments in the global industry over the last two years, including M&As, partnerships, clinical studies, pipelines (R&D), product approvals and launches, recalls and litigations, market dynamics, market drivers and restraints.

Why one should buy this report

The report can be instrumental in formulating strategic decisions to:

  • Make a regional strategy based on regional landscape and market characteristics.
  • Capitalise on opportunities in high-growth angioplasty regions/markets.
  • Plan capital investments based on the forecast for high angioplasty markets.
  • Prepare strategic presentations for the management, investors and shareholders.


1. Table of Contents
1.1 List of Charts
1.2 List of Tables
2. Executive Summary
3. Introduction
3.1 Classification of Stents
3.2 Timeline for stents
4. Coronary Stents
4.1 Introduction
4.1.1 Coronary stents are primarily classified based on material used and its content
4.1.2 Characteristics and Complications of Coronary Stents
4.1.3 Materials Used in Coronary Stents
4.1.4 Market Drivers
5. Coronary Stents - Market Drivers
5.1 Market Drivers for Coronary Stents
5.1.1 Aging Population
5.1.2 Obesity
5.1.3 Diabetes
5.1.4 Innovation Is a Key to Success
5.1.5 Regulatory Approvals
5.1.6 Emerging Markets Would Fuel Growth Of Stents
5.1.7 Players in the Global Market and Indian Market
6. Types of Stents
6.1 Established
6.1.1 Bare Metal Stent (BMS)
6.1.2 Drug Eluting Stent (DES)
6.2 Newer Generation Stents – Bioactive and Bioabsorbable Stents
6.2.1 Bioactive Stent (BAS)
6.2.2 Bioabsorbable Stent
7. Approvals
8. Competitive Landscape - Global
9. Global Clinical Studies
9.1 Products in Development
9.2 Comparative Trials
9.3 PMS and Registry Studies
9.4 Clinical Studies for New Geography
9.5 Existing Stents in New Indications
10. India Market for Coronary Stents (2007-2020)
10.1 Coronary Stents Cross Segment Analysis
10.2 Coronary Stents Revenue ($mn) by Segment
10.3 Coronary Stents Volume (Units) by Segment
10.4 Coronary Stents Average Prices ($)
10.5 India Coronary Stents Company Shares, 2014
11. Growth of Cath Labs in India
12. India – Coronary Angioplasty Data
12.1 India Coronary Angioplasty Data (2014)
13. State and City Wise Data - # PCIs and Coronary Stents
13.1 Maharashtra
13.1.1 Mumbai – No. of PCIs in 2014
13.1.2 Pune – No. of PCIs in 2014
13.1.3 Nagpur – No. of PCIs in 2014
13.1.4 Shirdi – No. of PCIs in 2014
13.1.5 Nashik – No. of PCIs in 2014
13.1.6 Aurangabad – No. of PCIs in 2014
13.1.7 Jalgaon – No. of PCIs in 2014
13.1.8 Latur – No. of PCIs in 2014
13.1.9 Kohlapur – No. of PCIs in 2014
13.1.10 Ahmednagar – No. of PCIs in 2014
13.1.11 Solapur – No. of PCIs in 2014
13.1.12 Nanded – No. of PCIs in 2014
13.1.13 Karad – Hospital
13.1.14 Yavatmal – No. of PCIs in 2014
13.1.15 Satara – No. of PCIs in 2014
13.1.16 Akola – No. of PCIs in 2014
13.1.17 Dhule – No. of PCIs in 2014
13.1.18 Amravati – No. of PCIs in 2014
13.1.19 Baramati – No. of PCIs in 2014
13.1.20 Vaduj – No. of PCIs in 2014
13.1.21 Ratnagiri – No. of PCIs in 2014
13.1.22 Sangli – No. of PCIs in 2014
13.2 Delhi NCR
13.2.1 Delhi – No. of PCIs in 2014
13.2.2 Gurgaon – No. of PCIs in 2014
13.2.3 Faridabad – No. of PCIs in 2014
13.2.4 Noida – No. of PCIs in 2014
13.2.5 Ghaziabad – No. of PCIs in 2014
13.3 Kerala
13.3.1 Trivandrum – No. of PCIs in 2014
13.3.2 Ernakulam – No. of PCIs in 2014
13.3.3 Perintalmanna – No. of PCIs in 2014
13.3.4 Kannur – No. of PCIs in 2014
13.3.5 Kottayam – No. of PCIs in 2014
13.3.6 Trichur – No. of PCIs in 2014
13.3.7 Calicut – No. of PCIs in 2014
13.3.8 Kollam – No. of PCIs in 2014
13.3.9 Palakkad – No. of PCIs in 2014
13.3.10 Kottakkal – No. of PCIs in 2014
13.3.11 Idukki – No. of PCIs in 2014
13.3.12 Parumala – No. of PCIs in 2014
13.3.13 Tiruvalla – No. of PCIs in 2014
13.3.14 Pala – No. of PCIs in 2014
13.3.15 Pathanamthitta – No. of PCIs in 2014
13.4 Andhra Pradesh and Telangana
13.4.1 Hyderabad – No. of PCIs in 2014
13.4.2 Guntur – No. of PCIs in 2014
13.4.3 Vijayawada – No. of PCIs in 2014
13.4.4 Vizag – No. of PCIs in 2014
13.4.5 Rajahmundry – No. of PCIs in 2014
13.4.6 Tirupati – No. of PCIs in 2014
13.4.7 Nellore – No. of PCIs in 2014
13.4.8 Karimnagar – No. of PCIs in 2014
13.4.9 Kakinada – No. of PCIs in 2014
13.4.10 Eluru – No. of PCIs in 2014
13.4.11 Nizamabad – No. of PCIs in 2014
13.5 Karnataka
13.5.1 Bangalore – No. of PCIs in 2014
13.5.2 Mangalore – No. of PCIs in 2014
13.5.3 Mysore – No. of PCIs in 2014
13.5.4 Udupi – No. of PCIs in 2014
13.5.5 Shimoga – No. of PCIs in 2014
13.5.6 Dharwad – No. of PCIs in 2014
13.5.7 Kolar – No. of PCIs in 2014
13.5.8 Hubli – No. of PCIs in 2014
13.5.9 Manipal – No. of PCIs in 2014
13.6 Tamil Nadu
13.6.1 Chennai – No. of PCIs in 2014
13.6.2 Coimbatore – No. of PCIs in 2014
13.6.3 Madurai – No. of PCIs in 2014
13.6.4 Vellore – No. of PCIs in 2014
13.6.5 Erode – No. of PCIs in 2014
13.6.6 Salem – No. of PCIs in 2014
13.6.7 Tirunelveli – No. of PCIs in 2014
13.6.8 Trichy – No. of PCIs in 2014
13.6.9 Nagercoil – No. of PCIs in 2014
13.6.10 Tuticorin – No. of PCIs in 2014
13.6.11 Cuddalore – No. of PCIs in 2014
13.7 Gujarat
13.7.1 Ahmadabad – No. of PCIs in 2014
13.7.2 Surat – No. of PCIs in 2014
13.7.3 Vadodara – No. of PCIs in 2014
13.7.4 Rajkot – No. of PCIs in 2014
13.7.5 Bhavnagar – No. of PCIs in 2014
13.7.6 Mehsana – No. of PCIs in 2014
13.8 Uttar Pradesh
13.8.1 Lukhnow – No. of PCIs in 2014
13.8.2 Meerut – No. of PCIs in 2014
13.8.3 Bareilly – No. of PCIs in 2014
13.8.4 Varanasi – No. of PCIs in 2014
13.8.5 Agra – No. of PCIs in 2014
13.8.6 Allahabad – No. of PCIs in 2014
13.8.7 Kanpur – No. of PCIs in 2014
13.9 Rajasthan
13.9.1 Jaipur – No. of PCIs in 2014
13.9.2 Jodhpur – No. of PCIs in 2014
13.9.3 Kota – No. of PCIs in 2014
13.9.4 Udaipur – No. of PCIs in 2014
13.9.5 Bikaner, Sikar and Bhiwadi – No. of PCIs in 2014
13.10 Punjab
13.10.1 Jalandar – No. of PCIs in 2014
13.10.2 Ludhiana– No. of PCIs in 2014
13.10.3 Amritsar – No. of PCIs in 2014
13.10.4 Bhatinda – No. of PCIs in 2014
13.10.5 Patiala – No. of PCIs in 2014
13.10.6 Nawanshar – No. of PCIs in 2014
13.10.7 Hoshiarpur – No. of PCIs in 2014
13.11 West Bengal
13.11.1 Kolkata – No. of PCIs in 2014
13.11.2 Durgapur – No. of PCIs in 2014
13.12 Madhya Pradesh
13.12.1 Indore – No. of PCIs in 2014
13.12.2 Bhopal – No. of PCIs in 2014
13.12.3 Jabalpur and Gwalior– No. of PCIs in 2014
13.13 Chandigarh/Mohali (Ajitgarh) – No. of PCIs in 2014
13.14 Odisha
13.14.1 Bhubaneswar – No. of PCIs in 2014
13.14.2 Cuttack – No. of PCIs in 2014
13.15 Chhattisgarh
13.15.1 Raipur – No. of PCIs in 2014
13.15.2 Bilaspur and Bhilai – No. of PCIs in 2014
13.16 Goa – No. of PCIs in 2014
13.17 Uttarakhand – No. of PCIs in 2014
13.18 Jharkhand – No. of PCIs in 2014
13.19 Puducherry – No. of PCIs in 2014
13.20 Jammu & Kashmir
13.20.1 Srinagar – No. of PCIs in 2014
13.20.2 Jammu – No. of PCIs in 2014
13.21 Haryana – No. of PCIs in 2014
13.22 Bihar – No. of PCIs in 2014
13.23 Meghalaya and Assam – No. of PCIs in 2014
14. Introduction to Supply & Distribution of Coronary Stents
14.1 Disparity in Stent Prices
14.2 Malpractice in Stents
14.3 Alternative Therapies
15. Recent Global Developments
16. Appendix
16.1 Research Methodology
16.1 Information Sources
16.2 Definitions
16.3 Disclaimer
Some of the list of Charts
Chart 1: In-depth classification of stents
Chart 2: Stent milestones
Chart 3: Stent placement procedure
Chart 4: Classification of coronary stents based on nature of material
Chart 5: Desirable stent characteristics and possible complications
Chart 6: Market Drivers – Coronary Stents
Chart 7: Growth of aging population in select countries
Chart 8: IHD mortality (33,744 deaths) versus usual total cholesterol by age
Chart 9: Rate of obesity in select countries in 2010
Chart 10: IHD mortality versus total cholesterol by BMI; systolic BP
Chart 11: Global diabetes burden
Chart 12: Growth of diabetic patients in matured and growing economies
Chart 13: Generation of stents
Chart 14: DREAMS provides scaffolding and paclitaxel release up to 3 months
Chart 15: Bioabsorption process of the BVS stent and relative degradation times
Chart 16: Growth of cardiovascular companies in emerging markets
Chart 17: Public healthcare expenditure
Chart 18: Market players
Chart 19: Cobalt alloy platform - better than stainless steel
Chart 20: Evolution of polymer free DES
Chart 21: Unmet needs of DES
Chart 22: Newer generation of stents to overcome the unmet needs of BMS & DES
Chart 23: TINOX trial - late loss reduced by 39%
Chart 24: 12- and 36-month MACE composition
Chart 25: Bioabsorbable stents are expected to establish synergy between conflicting requirements
Chart 26: High unmet needs in existing stents led invention of bioactive & bioabsorbable stents
Chart 27: Completely bioabsorbable stents may have drug or may be drug free
Chart 28: India, Coronary Stents, Cross Segment Analysis, 2007-2020
1.2 List of Tables
Table 1: Commonly used materials for coronary stents
Table 2: Innovations and approvals
Table 3: Regulatory approvals
Table 4: Biodegradable polymers offers low ST & better clinical outcomes over permanent
Table 5: Stent approval status - US, EU and Japan
Table 6: Approvals between 2002 and 2009
Table 7: Competitive landscape
Table 8: Competitive landscape
Table 9: Distribution of companies in four major geographies
Table 10: Stents undergoing clinical studies for the approvals
Table 11: Comparative trials - new v/s existing stents
Table 12: Clinical comparison and comparative trials (existing vs existing)
Table 13: Clinical studies under PMS and registries
Table 14: Pending one geography
Table 15: Existing stents in new and promising indications
Table 16: India, Coronary Stents, Cross Segment Analysis, 2007-2020
Table 17: India, Coronary Stents, Revenue ($mn), 2007-2014
Table 18: India, Coronary Stents, Revenue ($mn), 2014-2019
Table 19: India, Coronary Stents, Volume (Units'000), 2007-2014
Table 20: India, Coronary Stents, Volume (Units'000), 2014-2019
Table 21: India, Coronary Stents, Average Prices ($), 2007-2014
Table 22: India, Coronary Stents, Average Prices ($), 2014-2019
Table 23: India, Coronary Stents, Company Shares (%), 2014
Table 24: Cath labs - India

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report